News Articles
Sector/Industry
Please Select
Company
30 September, 2024
BirdDog Technology Eyes Turnaround at RaaS Research Webinar: Margins, New Products, and the Rise of Remedi
BirdDog Technology (ASX: BDT), a Melbourne-based innovator in broadcast-quality video technology, has had a challenging year, but the company now appears well-positioned for a significant turnaround....
16 September, 2024
Memphasys achieves positive initial study results from Felix equine application
Australian bioseperation biotechnology company Memphasys (ASX: MEM) has obtained positive results from an initial study validating the commercial potential of its Felix System in improving the...
12 September, 2024
Memphasys to Raise $2 Million for Felix Commercialisation Push
In the world of biotech, timing is everything, and for Memphasys Limited (ASX: MEM), the clock is ticking as it gears up to unlock the commercial potential of its flagship Felix™ System. The...
22 August, 2024
ABx receives R&D Tax Rebate for ALCORE
ABx Group's (ASX: ABX) 83%-owned subsidiary ALCORE Limited has received a research & development (R&D) tax offset of $474,126.21 from the Australian Taxation Office (ATO) for activities undertaken...
29 July, 2024
Memphasys secures $1M from major shareholder and R&D Tax Rebate loan
Australian reproductive biotechnology company Memphasys Limited’s (ASX: MEM) major shareholder Andrew Goodall has entered into a Subscription Agreement with the company to raise $500,000.